Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 401 | 2.810 |
Why?
|
| Mammography | 12 | 2017 | 43 | 2.100 |
Why?
|
| Kidney Failure, Chronic | 18 | 2021 | 123 | 1.990 |
Why?
|
| Racism | 4 | 2022 | 26 | 1.810 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 100 | 1.680 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 74 | 1.670 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 104 | 1.630 |
Why?
|
| Registries | 17 | 2011 | 172 | 1.510 |
Why?
|
| Health Status Disparities | 5 | 2020 | 68 | 1.490 |
Why?
|
| Renal Replacement Therapy | 10 | 2011 | 18 | 1.480 |
Why?
|
| Kidney Transplantation | 9 | 2021 | 114 | 1.370 |
Why?
|
| Medically Uninsured | 2 | 2021 | 12 | 1.170 |
Why?
|
| Physicians | 2 | 2022 | 106 | 1.070 |
Why?
|
| Humans | 77 | 2023 | 23169 | 1.040 |
Why?
|
| Primary Health Care | 3 | 2021 | 76 | 0.860 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 97 | 0.850 |
Why?
|
| Female | 57 | 2021 | 13059 | 0.840 |
Why?
|
| Middle Aged | 44 | 2021 | 8000 | 0.840 |
Why?
|
| Chicago | 23 | 2019 | 816 | 0.780 |
Why?
|
| Health Facilities | 1 | 2023 | 26 | 0.780 |
Why?
|
| Health Equity | 1 | 2023 | 13 | 0.780 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 123 | 0.770 |
Why?
|
| Renal Dialysis | 11 | 2021 | 82 | 0.760 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.750 |
Why?
|
| Adult | 37 | 2021 | 7031 | 0.730 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 125 | 0.730 |
Why?
|
| Referral and Consultation | 3 | 2021 | 81 | 0.720 |
Why?
|
| Health Personnel | 1 | 2022 | 87 | 0.700 |
Why?
|
| Socioeconomic Factors | 12 | 2020 | 270 | 0.700 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 34 | 0.700 |
Why?
|
| Community Health Services | 1 | 2021 | 30 | 0.700 |
Why?
|
| Dyslipidemias | 2 | 2018 | 15 | 0.690 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 43 | 0.670 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 291 | 0.660 |
Why?
|
| Hospitalization | 2 | 2022 | 290 | 0.640 |
Why?
|
| Mass Screening | 10 | 2017 | 167 | 0.630 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 254 | 0.630 |
Why?
|
| Aged | 33 | 2021 | 7498 | 0.630 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 6 | 0.610 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 3 | 0.610 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 29 | 0.590 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 243 | 0.580 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 27 | 0.570 |
Why?
|
| Violence | 1 | 2018 | 35 | 0.570 |
Why?
|
| Survival Rate | 7 | 2011 | 323 | 0.560 |
Why?
|
| Mortality | 5 | 2018 | 74 | 0.520 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 40 | 0.490 |
Why?
|
| Residence Characteristics | 5 | 2019 | 175 | 0.490 |
Why?
|
| United Kingdom | 12 | 2011 | 40 | 0.480 |
Why?
|
| Male | 33 | 2021 | 12556 | 0.470 |
Why?
|
| Health Policy | 2 | 2015 | 34 | 0.470 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 1 | 0.470 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.460 |
Why?
|
| Insurance Coverage | 1 | 2015 | 10 | 0.460 |
Why?
|
| Young Adult | 13 | 2021 | 1671 | 0.450 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 19 | 0.450 |
Why?
|
| Peritoneal Dialysis | 3 | 2011 | 26 | 0.430 |
Why?
|
| Hospitals | 4 | 2022 | 157 | 0.410 |
Why?
|
| United States | 10 | 2021 | 1820 | 0.410 |
Why?
|
| Cause of Death | 4 | 2011 | 57 | 0.400 |
Why?
|
| Waiting Lists | 2 | 2010 | 18 | 0.390 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 13 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 557 | 0.390 |
Why?
|
| Retrospective Studies | 12 | 2021 | 3026 | 0.380 |
Why?
|
| Tissue Donors | 2 | 2010 | 63 | 0.380 |
Why?
|
| Community Health Planning | 2 | 2009 | 14 | 0.380 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 686 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 774 | 0.370 |
Why?
|
| Adolescent | 9 | 2021 | 1916 | 0.360 |
Why?
|
| Hemoglobins | 4 | 2009 | 27 | 0.360 |
Why?
|
| Risk Factors | 11 | 2018 | 1988 | 0.340 |
Why?
|
| National Health Programs | 2 | 2010 | 3 | 0.330 |
Why?
|
| Cesarean Section | 4 | 2014 | 29 | 0.330 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 3754 | 0.330 |
Why?
|
| Risk Assessment | 7 | 2018 | 552 | 0.330 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 13 | 0.330 |
Why?
|
| Community Participation | 1 | 2009 | 17 | 0.310 |
Why?
|
| Incidence | 9 | 2019 | 635 | 0.310 |
Why?
|
| ErbB Receptors | 1 | 2009 | 54 | 0.300 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.300 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.300 |
Why?
|
| Medical Audit | 1 | 2008 | 5 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 321 | 0.290 |
Why?
|
| Smoking | 2 | 2005 | 168 | 0.270 |
Why?
|
| Poverty | 6 | 2010 | 92 | 0.270 |
Why?
|
| Hospitals, Public | 6 | 2002 | 27 | 0.260 |
Why?
|
| Diabetes Mellitus | 3 | 2005 | 109 | 0.260 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.250 |
Why?
|
| Guideline Adherence | 3 | 2018 | 56 | 0.240 |
Why?
|
| Intubation | 1 | 2005 | 6 | 0.240 |
Why?
|
| Public Health | 2 | 2017 | 62 | 0.240 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.240 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 13 | 0.240 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.240 |
Why?
|
| Treatment Outcome | 5 | 2018 | 2971 | 0.230 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 18 | 0.230 |
Why?
|
| Smoking Cessation | 1 | 2005 | 45 | 0.220 |
Why?
|
| Time Factors | 6 | 2018 | 1275 | 0.220 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 639 | 0.220 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 8 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 67 | 0.210 |
Why?
|
| New Zealand | 6 | 2019 | 10 | 0.210 |
Why?
|
| Asthma | 1 | 2005 | 150 | 0.210 |
Why?
|
| Cities | 3 | 2018 | 13 | 0.200 |
Why?
|
| Commerce | 1 | 2023 | 10 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 33 | 0.200 |
Why?
|
| Patient Transfer | 2 | 1996 | 25 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2019 | 312 | 0.190 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.190 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 12 | 0.190 |
Why?
|
| Morbidity | 2 | 2001 | 51 | 0.180 |
Why?
|
| Health Priorities | 1 | 2001 | 3 | 0.180 |
Why?
|
| Public Health Administration | 1 | 2001 | 9 | 0.180 |
Why?
|
| Patient Compliance | 3 | 2018 | 145 | 0.180 |
Why?
|
| Social Class | 3 | 2010 | 54 | 0.180 |
Why?
|
| Aftercare | 1 | 2021 | 22 | 0.180 |
Why?
|
| Research Design | 2 | 2020 | 157 | 0.170 |
Why?
|
| Health Surveys | 3 | 2007 | 79 | 0.170 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.160 |
Why?
|
| Neoplasms | 2 | 2017 | 219 | 0.160 |
Why?
|
| Income | 2 | 2005 | 66 | 0.160 |
Why?
|
| England | 5 | 2011 | 14 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 72 | 0.160 |
Why?
|
| Cholesterol | 2 | 2018 | 57 | 0.160 |
Why?
|
| Prevalence | 6 | 2014 | 384 | 0.160 |
Why?
|
| Sociology, Medical | 1 | 2019 | 2 | 0.150 |
Why?
|
| Comorbidity | 3 | 2017 | 428 | 0.150 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 34 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 96 | 0.150 |
Why?
|
| Illinois | 4 | 2015 | 220 | 0.150 |
Why?
|
| Survival Analysis | 2 | 2009 | 244 | 0.150 |
Why?
|
| Mortality, Premature | 1 | 2018 | 5 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 31 | 0.140 |
Why?
|
| Biomarkers | 2 | 2018 | 476 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 16 | 0.140 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 19 | 0.140 |
Why?
|
| Infant, Newborn | 5 | 2019 | 538 | 0.140 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.140 |
Why?
|
| Germany | 1 | 2017 | 6 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 173 | 0.140 |
Why?
|
| Wales | 4 | 2010 | 5 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2017 | 90 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 143 | 0.130 |
Why?
|
| Prognosis | 4 | 2012 | 740 | 0.130 |
Why?
|
| Health Education | 3 | 1994 | 43 | 0.130 |
Why?
|
| False Negative Reactions | 1 | 2016 | 13 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 449 | 0.130 |
Why?
|
| Quality Control | 1 | 2016 | 25 | 0.130 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 1 | 0.130 |
Why?
|
| Observer Variation | 1 | 2016 | 85 | 0.130 |
Why?
|
| Urban Health | 3 | 2004 | 20 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 30 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 359 | 0.130 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 16 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 132 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 32 | 0.120 |
Why?
|
| Cohort Studies | 6 | 2019 | 1425 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 30 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 34 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 4 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 258 | 0.120 |
Why?
|
| Financing, Government | 1 | 2015 | 8 | 0.120 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.110 |
Why?
|
| Stereotyping | 1 | 2015 | 17 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2015 | 26 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 38 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 592 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2015 | 44 | 0.110 |
Why?
|
| Students, Medical | 1 | 2015 | 53 | 0.110 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 3 | 0.110 |
Why?
|
| Syphilis | 1 | 1994 | 2 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 12 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 6 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 21 | 0.100 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 87 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 1427 | 0.090 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 2 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 13 | 0.090 |
Why?
|
| Europe | 4 | 2010 | 53 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 16 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 77 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1512 | 0.080 |
Why?
|
| Patient Selection | 2 | 2011 | 168 | 0.080 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| HIV Infections | 1 | 1994 | 424 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 19 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 36 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 17 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 224 | 0.070 |
Why?
|
| Counseling | 1 | 2008 | 39 | 0.070 |
Why?
|
| Logistic Models | 1 | 2009 | 357 | 0.070 |
Why?
|
| Interviews as Topic | 2 | 2002 | 116 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 439 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 15 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 51 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 37 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 743 | 0.060 |
Why?
|
| Parathyroid Hormone | 3 | 2010 | 23 | 0.060 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 486 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 168 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 3 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 578 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 12 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 20 | 0.060 |
Why?
|
| Critical Care | 1 | 2005 | 110 | 0.050 |
Why?
|
| Attitude to Health | 3 | 2011 | 94 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 13 | 0.050 |
Why?
|
| Educational Status | 1 | 2005 | 214 | 0.050 |
Why?
|
| Lung | 1 | 2004 | 153 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 247 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 523 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 76 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1098 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1171 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 8 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 9 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 219 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 1998 | 62 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 107 | 0.040 |
Why?
|
| Phosphates | 2 | 2010 | 16 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 13 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 26 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 24 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 13 | 0.040 |
Why?
|
| North America | 1 | 2018 | 32 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 2 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 82 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 15 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 17 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 106 | 0.030 |
Why?
|
| Calcium | 2 | 2010 | 358 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 481 | 0.030 |
Why?
|
| Community Health Centers | 3 | 1993 | 11 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 54 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 13 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 19 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 22 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 42 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 4 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 58 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 114 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 30 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 154 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 9 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 38 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 1 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 1 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 7 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 5 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 5 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 26 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 27 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 22 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 274 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 9 | 0.020 |
Why?
|
| Bicarbonates | 1 | 2009 | 2 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 161 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 12 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 2 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 3 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 19 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2006 | 2 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 18 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1048 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 12 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 133 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 27 | 0.010 |
Why?
|
| Physical Examination | 2 | 1993 | 87 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 6 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 234 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 14 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 83 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 9 | 0.000 |
Why?
|
| Time | 1 | 1986 | 14 | 0.000 |
Why?
|